EHA

Blood cells
#Blood cancer #Clinical trials #EHA #Haematology #Oncology

Data highlights from EHA 2025

The latest new trial data presented at the 30th European Hematology Association (EHA) 2025 Congress.  Bispecific antibody for diffuse large B-cell lymphoma Genmab shared new results from the Phase Ib/II EPCORE NHL-2 trial Arm 10 trial evaluating epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously,… Read More

#Cancer Research #News